Literature DB >> 21677444

Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-β₁ in patients with chronic kidney disease.

Julia Lepenies1, Kevin S Eardley, Tina Kienitz, Martin Hewison, Thomas Ihl, Paul M Stewart, Paul Cockwell, Marcus Quinkler.   

Abstract

BACKGROUND: Toll-like receptor-4 (TLR4) has been implicated in the pathogenesis of different renal diseases in rodent models. However, in human kidney disease, TLR4 expression and regulation is not well understood. We hypothesized that renal TLR4 expression plays a role in chronic kidney disease (CKD) and is associated with proteinuria, kidney function, histological diagnosis, and inflammatory mediators.
METHODS: We quantified TLR4 mRNA as well as expression of macrophage chemoattractant protein-1 (MCP-1), transforming growth factor-β₁ (TGF-β₁) and interleukin-6 (IL-6) in human kidney biopsies from 70 patients with CKD. We measured kidney function, urinary MCP-1 protein excretion, and the amount of chronic damage. Macrophage load was quantified by CD68 and vascularization by CD34 immunostaining.
RESULTS: TLR4 expression correlated significantly with MCP-1 and TGF-β₁ expression. High TLR4 expression was associated with high IL-6 expression. TLR4 expression was significantly upregulated in patients with severe proteinuria, and in patients with chronic ischemic renal damage and IgA nephropathy, when compared to patients with thin glomerular basement membrane disease. TLR4 expression did not correlate with creatinine clearance, renal outcome, macrophage load or chronic damage.
CONCLUSIONS: We show for the first time that renal TLR4 expression was significantly associated with the pro-inflammatory marker MCP-1 and the profibrotic molecule TGF-β₁ in kidney biopsies from patients with CKD, suggesting that increased expression of TLR4 is an important feature of CKD. 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21677444     DOI: 10.1159/000324765

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  23 in total

Review 1.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

Review 2.  Controversial role of toll-like receptors in acute pancreatitis.

Authors:  Juan Vaz; Hamid Akbarshahi; Roland Andersson
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

3.  The Increased Expression of Toll-Like Receptor 4 in Renal and Skin Lesions in Lupus Erythematosus.

Authors:  Nesrine Elloumi; Raouia Fakhfakh; Lobna Ayadi; Khadija Sellami; Olfa Abida; Mariem Ben Jmaa; Tahya Sellami; Khawla Kammoun; Hatem Masmoudi
Journal:  J Histochem Cytochem       Date:  2017-05-22       Impact factor: 2.479

4.  Genetic Variants in Toll-Like Receptor 4 Gene and Their Association Analysis with Estimated Glomerular Filtration Rate in Mexican American Families.

Authors:  Farook Thameem; Sobha Puppala; Vidya S Farook; Balakuntalam S Kasinath; John Blangero; Ravindranath Duggirala; Hanna E Abboud
Journal:  Cardiorenal Med       Date:  2016-05-20       Impact factor: 2.041

5.  Acute toll-like receptor 4 activation impairs rat renal microvascular autoregulatory behaviour.

Authors:  J P Van Beusecum; S Zhang; A K Cook; E W Inscho
Journal:  Acta Physiol (Oxf)       Date:  2017-06-27       Impact factor: 6.311

6.  Antagonism of major histocompatibility complex class II invariant chain peptide during chronic lipopolysaccharide treatment rescues autoregulatory behavior.

Authors:  Justin P Van Beusecum; Shali Zhang; Estevan Beltran; Anthony K Cook; Richard P Tobin; M Karen Newell-Rogers; Edward W Inscho
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-21

Review 7.  Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

Authors:  Kristen Renee McSweeney; Laura Kate Gadanec; Tawar Qaradakhi; Benazir Ashiana Ali; Anthony Zulli; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

Review 8.  Genomic approaches in the search for molecular biomarkers in chronic kidney disease.

Authors:  M Cañadas-Garre; K Anderson; J McGoldrick; A P Maxwell; A J McKnight
Journal:  J Transl Med       Date:  2018-10-25       Impact factor: 5.531

Review 9.  Innate immunity in donor procurement.

Authors:  Kitty P Cheung; Sashi G Kasimsetty; Dianne B McKay
Journal:  Curr Opin Organ Transplant       Date:  2013-04       Impact factor: 2.640

10.  Clarithromycin attenuates the expression of monocyte chemoattractant protein-1 by activating toll-like receptor 4 in human mesangial cells.

Authors:  Koji Tsugawa; Tadaatsu Imaizumi; Shojiro Watanabe; Kazushi Tsuruga; Hidemi Yoshida; Hiroshi Tanaka
Journal:  Clin Exp Nephrol       Date:  2016-09-10       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.